Rein Therapeutics, Inc. (RNTX) analyst actions
Rating and price-target actions on RNTX in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the RNTX overview →
1 measured RNTX analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Rein Therapeutics Announces Initiation of RENEW Phase 2 Trial of LTI-03 in Patients with IPF | Press release | +0.00% | +1.12% |
Keep exploring
More RNTX: earnings → · SEC filings → · RNTX overview →